Gilead and Merck Report Positive Phase 3 Results f...
Category : Clinical Trial Update 11 June 2026The way HIV is treated has changed dramatically over the last few decades. Daily antiretroviral ther...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Caliway Presents New Data on CBL-514 Combination T...
Category : Clinical Trial Update 11 June 2026Caliway Biopharmaceuticals has announced new preclinical data for its investigational drug candidate...
Elixiron Reports Positive Phase 2 Interim Results...
Category : Clinical Trial Update 11 June 2026Elixiron Immunotherapeutics has announced encouraging interim results from its ongoing Phase 2 proof...
Pfizer Highlights Promising Phase 2 Results for Mo...
Category : Clinical Trial Update 10 June 2026Pfizer has shared new data from several Phase 2b clinical studies of berobenatide (PF-07976016), an...
Lynk Pharmaceuticals Reaches Key Clinical Mileston...
Category : Clinical Trial Update 10 June 2026Lynk Pharmaceuticals has announced an important step forward in the development of its investigation...
Latest Newsletter Post
-
Elixiron Reports Positive Phase 2 I..
11 June 2026
-
Caliway Presents New Data on CBL-51..
11 June 2026
-
Gilead and Merck Report Positive Ph..
11 June 2026
-
Lynk Pharmaceuticals Reaches Key Cl..
10 June 2026
-
Pfizer Highlights Promising Phase 2..
10 June 2026
